Evaluation of Salivary Glucose, IgA and Flow Rate in Diabetic Patients: A Case-Control Study by Bakianian Vaziri, P. et al.
 
2010; Vol. 7, No. 1  13
Original Article   
Evaluation of Salivary Glucose, IgA and Flow Rate in  
Diabetic Patients: A Case-Control Study 
P. Bakianian Vaziri
 1, M. Vahedi
 2, 3~, H. Mortazavi
 2, 3, Sh. Abdollahzadeh
 2, 3,  
M. Hajilooi
 3, 4 
1  Assistant Professor, Department of Oral Medicine, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran,
Iran 
2  Assistant Professor, Department of Oral Medicine, School of Dentistry, Hamadan University of Medical Sciences, Hamadan, Iran
3  Assistant Professor, Dental Research Center, Hamadan University of Medical Sciences, Hamadan, Iran 
4  Assistant Professor, Department of Oral Pathology, School of Dentistry, Hamadan University of Medical Sciences, Hamadan, Iran
 
~ Corresponding author:  
M. Vahedi, Assistant Professor, 
Department of Oral Medicine, 
School of Dentistry, Hamadan 
University of Medical Sciences, 
Hamadan, Iran. 
vahedi_md@yhaoo.com 
 
Received: 20 January 2009 
Accepted:20 May 2009 
Abstract: 
Objective: An association between diabetes mellitus and alterations in the oral cavity has
been noted. In this study, we evaluated differences between salivary IgA, glucose and flow
rate in diabetic patients compared with healthy controls. 
Materials and Methods: Forty patients with type 1 diabetes, 40 patients with type 2 di-
abetes and 40 healthy controls were selected. Whole unstimulated saliva samples were 
collected by the standard method and the salivary flow rate was determined. Nephelome-
tric and Pars method were used to measure salivary IgA and salivary glucose concentra-
tions, respectively. Statistical analysis was performed by Chi-square and t test. 
Results: There were no significant differences in salivary IgA and glucose concentrations
between type 1 and type 2 diabetic patients and their matched control subjects (P>0.05). 
Salivary flow rate was significantly lower in diabetic patients (P<0.05). In addition, 
DMFT was higher in diabetic patients than the controls. 
Conclusion: Determination of salivary constituents may be useful in the description and 
management of oral findings in diabetic patients. 
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INTRODUCTION 
Diabetes mellitus is a metabolic syndrome 
characterized by hyperglycemia and distur-
bances in the metabolism of carbohydrates, 
proteins, and lipids [1]. Hyperglycemia is the 
main characteristic of diabetes which results 
from insufficient insulin secretion and hepatic 
gluconeogenesis [2,3]. Type 1 or insulin de-
pendent diabetes and type 2 or none insulin 
dependent diabetes are the two major types of 
diabetes. The worldwide figure of people with 
diabetes is set to rise from 180 million in year 
2000 to 320 million in 2025 [4,5]. This disease 
is clinically complex and associated with many 
complications such as nephropathy, retinopa-
thy, neuropathy and cardiovascular diseases 
[6,7]. In addition, some oral complications in 
diabetic patients are xerostomia, tooth loss, 
gingivitis, periodontitis, odontogenic abscesses 
and soft tissue lesions of the tongue and oral 
mucosa [6,8,9]. It has been reported that the 
alterations in salivary flow rate and its compo-
sitions could affect the development, symp-
toms and severity of oral changes in diabetic 
patients and it also has been noted that detec-
tion of salivary constituents in diabetic patients Journal of Dentistry, Tehran University of Medical Sciences   Bakianian Vaziri et al. 
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may be useful in the understanding and man-
agement of the oral manifestations [10-12]. 
 
MATERIALS AND METHODS 
The patients participated in this study con-
sisted of forty 9 to 61-year-old subjects with 
type 1 diabetes (19 male/ 21 female) and forty 
39 to 82-year-old subjects with type 2 diabetes 
(20 male/20 female) from the Center of Di-
abetes Research in Hamadan, 2008. The con-
trol group consisted of 40 clinically healthy 
people (20 male /20 female) in the age range 
of 39 to 67 years who had been referred to Be-
sat Hospital, Hamadan. Because of the age and 
weight differences between type 1 and 2 di-
abetes, the control subjects were divided into 
two sub groups according to age, sex, and 
weight. Exclusion criteria for the control group 
were pregnancy, alcohol dependency, smoking 
(former and current), any chronic diseases and 
history of diabetes within the previous years. 
Consequently, the control subjects did not re-
port any health problems and did not take any 
medication other than vitamins or occasional 
analgesics. After explaining and completing an 
informed consent, all subjects were asked not 
to eat, drink (except water) and smoke for an 
overnight period prior to collection of saliva 
samples.  
In addition, DMFT index was taken in diabetic 
patients and control subjects as a part of oral 
health assessment. Unstimulated whole saliva 
from the diabetic patients and control subjects 
was collected using the Navazesh method [13]. 
Collection of unstimulated whole saliva was 
done from each subject between 8:00 and 
10:00 am. Firstly, the subjects were asked to 
swallow saliva and then stay motionless and 
allow the saliva to passively drain for five mi-
nutes over the lower lip into a pre-weighed test 
tube fitted by a funnel. Salivary flow rate vo-
lume was determined with a standard glass 
container. The saliva samples were centrifuged 
at 4000 rpm for 15 minutes to remove any par-
ticulate material and then supernatants were 
immediately frozen at -70˚C and stored for 
later analysis [1,13]. IgA was assessed by the 
nephelometric method (Minineph
 TM Human 
Kit, Binding Site Ltd, Birmingham, UK) and 
glucose by Pars method (glucose Oxidase Kit, 
Pars Azmoon Co, Tehran, Iran). Statistical 
analysis was performed using SPSS version 16 
for windows software. All values were re-
ported as mean (SD). The statistical significa-
tion was measured by t-test and Chi-square 
test for quantitative and qualitative variables, 
respectively. P value, less than 0.05 was con-
sidered as significant. 
 
RESULTS 
Demographic data of the subjects are shown in 
Table 1. There were no significant differences 
between the patients and control subjects con-
sidering sex, age, and weight. Salivary IgA, 
glucose, and flow rate values in diabetic pa-
tients and control groups are shown in Table 2. 
There were no significant differences in sali-
vary IgA between type 1 diabetic patients and 
control group 1 (P=0.15). This was the same 
for type 2 diabetic patients and control group 2 
(P=0.67). No significant difference in salivary 
glucose concentration was found between type 
1 diabetic patients and control group 1 
(P=0.88) as well as type 2 diabetic patients and 
                
Table 1. Characteristics of patients with diabetes mellitus and control subjects. 
Group  Age (year)    Sex    Weight (Kg) 
mean
  SD range  (male/female)  mean
  SD range 
Type1 diabetes (n=40) 
a 28.8
  11.63 (9-61)  
c(19.21)  
e62.92
  9.92
  (28-86)
Control 1 subjects (n=20) 
a 27.65  5.65 (20-38)  
c(10.10)  
e62.55 13.59
  (47-80)
Type2 diabetes (n=40) 
b54.02 10.10 (39-82)  
d(20.20)  
f61.35 11.43
  (50-86)
Control 2 subject (n=20) 
b54.3 7.11 (40-67)  
d(10.10)  
f71.9 10.31
  (54-90)
a,b,c,d,e,f: Values with the same letters were not significantly different (P> 0.05).
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control group 2 (P=0.19). However, the sali-
vary flow rate was significantly lower in type 
1 and type 2 diabetic patients compared to the 
matched control groups (P=0.000 and 
P=0.001, respectively). Moreover, there were 
no significant differences in salivary IgA 
(P=0.12) and glucose concentrations (P=0.18) 
between type 1 and type 2 diabetic patients. 
DMFT index was higher in the two diabetic 
patient groups than their matched control sub-
jects (Table 3). 
 
DISCUSSION 
Blood sample is the most common biologic 
fluid utilized for diagnosis and monitoring of 
diseases. However, whole saliva is frequently 
studied as an alternative for blood that can be 
useful even for diagnostic purposes. Whole 
saliva contains locally produced substances as 
well as serum components that can be used for 
diagnosis of a variety of systemic diseases and 
understanding of their oral manifestations [14]. 
Two of the advantages of salivary assessment 
are its non-invasive collection and cost effec-
tiveness for screening large populations [14]. 
Mata et al [15] reported alterations of salivary 
composition in diabetic patients. These biolog-
ic changes in diabetic whole saliva were dif-
ferent from one study to another that may be 
due to the diversity in sample selection criteria 
and study design [16]. In this study, we found 
no significant differences in salivary IgA le-
vels between diabetic patients and their 
matched controls. Yavuzyilmaz et al [10] 
demonstrated a significant increase in salivary 
IgA levels in diabetic patients. They suggested 
that it could be related to local factors such as 
calculus and higher bacterial plaque accumula-
tion in these patients. The findings of this 
study on salivary IgA levels were in contrast 
with other studies [17-19]. These differences 
may be due to differences in the type of saliva 
collected (stimulated or unstimulated), the sa-
livary collection methods, the stage of the dis-
ease, and the metabolic control status of the 
disease. The salivary glucose concentrations in 
the present study were in disagreement with 
other studies [18,20-22]. Belazi et al [18] 
showed higher salivary and serum glucose 
concentrations in children with insulin depen-
dent diabetes mellitus. Aydin [20] showed that 
salivary glucose and α-Amylase levels were 
higher in diabetic subjects than controls.  
Darwazeh et al [21] demonstrated concentra-
tion of salivary glucose was related to blood 
glucose but there was no relationship with 
HbA1c. Furthermore, Kjellman [22] detected 
higher levels of glucose in the whole saliva 
and gingival fluid of patients with diabetes 
mellitus. These differences may be due to the 
diabetes status and glycemic control. Reuterv-
ing et al [23] demonstrated that salivary glu-
cose concentration was lower during better 
glycemic control. Review of the literature 
about salivary flow rate in diabetic patients has 
demonstrated some differences [20].  
Salivary flow rate in the present study was de-
creased in diabetic patients but this finding 
was in disagreement with Lamey et al study 
[24]. Aydin [20] has also showed no difference 
                  
Table 2. Salivary IgA, glucose, and flow rate values in diabetic patients and control subjects. 
Groups  IgA (mg/l)    Glucose (mg/dl)    Flow Rate (ml/min) 
Mean SD P  value    Mean SD P value    Mean  SD  P value 
Type1 Diabetes  0.100  0.150  0.15   14.52 10.46 0.88   0.21  0.09 0.000 
Control 1  0.069  0.030     14.82 8.36     0.49  0.27  
Type2 Diabetes  0.066  0.032  0.67   18.67 16.54 0.19   0.32  0.14 0.001 
Control 2  0.067  0.200     15.61 9.10     0.39  0.17  
Type1 Diabetes  0.100  0.150  0.12   14.52 10.46 0.18       
Type2 Diabetes  0.066  0.032     18.67 16.54         
SD= Standard Deviation 
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in the salivary flow rate between diabetic and 
control subjects. Nevertheless, a decreased sa-
livary flow rate has been noted in diabetic pa-
tients by Ogunbodede et al, Chávez et al, and 
López et al [25-27]. Negative effects of di-
abetes mellitus on the sympathetic and para-
sympathetic nervous system, microangiopathy, 
dehydration and hormonal changes may cause 
discrepancies in the salivary flow rate [11,28]. 
In addition, it was demonstrated that neuropa-
thies affecting the parasympathetic or sympa-
thetic nervous system might have different ef-
fects on the flow rate and composition of sali-
va [19].  
DMFT index in the present study was higher 
in diabetic patients compared with control sub-
jects. Decreasing the salivary flow rate and 
xerostomia may result in dental problems and 
is compatible with a higher rate of DMFT, 
which was in agreement with Collin’s et al 
study [28]. Moreover, the higher rate of dental 
problems in diabetic patients may be related to 
salivary dysfunction, existing acidogenic mi-
croorganisms, poor glycemic control, poor 
dental hygiene and higher dental plaques 
[26,29,30]. It has been noted that the antimi-
crobial function of saliva is not impaired in 
diabetic patients but caries protective proper-
ties of saliva might be less effective [28]. 
 
CONCLUSION 
In the present study, no significant differences 
were found in salivary IgA and glucose con-
centrations between type 1 and type 2 diabetic 
patients and control subjects. Significantly, 
lower salivary flow rate and higher DMFT 
values were observed in diabetic patients when 
compared to the controls. Since alterations in 
the oral cavity may have some role in the de-
velopment and severity of oral changes, de-
termination and monitoring salivary constitu-
ents may be useful in the description and man-
agement of oral findings in diabetic patients. 
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